Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol

Authors

Anita Pelecanos (ORCID: https://orcid.org/0000-0003-0197-4504)
Ristan M. Greer (ORCID: https://orcid.org/0000-0002-1574-4729)
Georgie Huggett
Taylan Gurgenci (ORCID: https://orcid.org/0000-0001-9695-9109)
Janet Hardy (ORCID: https://orcid.org/0000-0003-1127-9951)
Phillip D. Good (ORCID: https://orcid.org/0000-0002-8198-0375)
Alison M Kearney (ORCID: https://orcid.org/0000-0002-3361-192X)

Institutions

The University of Queensland (AU)
QIMR Berghofer Medical Research Institute (AU)
Royal Brisbane and Women's Hospital (AU)
Mater Misericordiae Hospital (AU)
Mater Research (AU)
St Vincent’s Private Hospital Brisbane (AU)

Publication Details

Journal: Supportive Care in Cancer
Published: 2025-07-24
DOI: https://doi.org/10.1007/s00520-025-09763-5
Citations: 3
Primary Topic: Cannabis and Cannabinoid Research
Type: article
Field-Weighted Citation Impact: 4.18

Funders

Mater Foundation
Australian Government
University of Queensland

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol

Anita Pelecanos, Ristan M. Greer, Georgie Huggett, Taylan Gurgenci et al.

Jul 24, 2025

3 citations

Supportive Care in Cancer

Cannabis and Cannabinoid Research

4.18

article

Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol

Anita Pelecanos, Ristan M. Greer, Georgie Huggett, Taylan Gurgenci, Janet Hardy, Phillip D. Good, Alison M Kearney

July 24, 2025article en

3 citations

Abstract

No abstract available for this paper.

Supportive Care in CancerVol. 33(8)

The University of Queensland (AU), QIMR Berghofer Medical Research Institute (AU), Royal Brisbane and Women's Hospital (AU), Mater Misericordiae Hospital (AU), Mater Research (AU), St Vincent’s Private Hospital Brisbane (AU)

Mater Foundation, Australian Government, University of Queensland

Good health and well-being

Openalex Percentile: Top 6%

Cannabis and Cannabinoid Research

4.18

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol — Anita Pelecanos, Ristan M. Greer, et al. · Supportive Care in Cancer (2025) | TGRS Research Map | TGRS